Cambrex

About Cambrex

Cambrex is a contract development and manufacturing organization (CDMO) that supports biotech and pharmaceutical companies by providing expertise and equipment for drug development and manufacturing. Their mission is to offer a competitive advantage through a collaborative, scientist-led approach, ensuring a seamless journey from early development to commercialization across the entire drug lifecycle.

Products & Services

Drug Substance:Services include development and manufacturing of challenging APIs and complex processes, covering custom API development, manufacturing (clinical and commercial), generic API production, peptide development, and specialty solutions like biocatalysis and highly potent APIs.

Drug Product:Offers formulation development and clinical trial manufacturing to advance drug products from concept to clinic, ensuring flexibility and quality in early development and scale-up preparation.

Analytical Services:Provides customized, phase-appropriate analytical programs, including testing, method development, microbiology, solid state chemistry, and stability storage to support drug development across the lifecycle.

Specialties

Drug Substance Development and Manufacturing API Manufacturing (Custom, Clinical, Commercial, Generic) Peptide Development and Manufacturing Analytical Testing and Services Formulation Development Clinical Trial Manufacturing Technology Transfer Specialty Solutions (Biocatalysis, Continuous Flow, Highly Potent APIs)

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Investment T: - FT: Investment	A: 120000000 MR: - FA: 120 million FAN: 120000000	D: 2025-10-22 FD: 2025-10-22	-
2	RT: Internal Investment T: - FT: Internal Investment	A: 100000000 MR: - FA: $100 million FAN: 100000000	D: 2024-03-18 FD: 2024-03-18	-
3	RT: Investment Plan T: - FT: Investment Plan	A: 100000000 MR: - FA: $100 million FAN: 100000000	D: 2024-03-18 FD: 2024-03-18	-

Investment Latest

2025-10-22

$120.0M

Internal Investment 2024-03-18

$100.0M

Investment Plan 2024-03-18

$100.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

D

David Ford

Senior Director of Chemistry, Snapdragon Chemistry

A

Antje Gupta

General Manager, Cambrex IEP GmbH

I

Ingrid Ekman

Director, R&D

G

Greg Buenger

Group Leader, Chemical Development

M

Miles Blackburn

Associate Director of Chemistry

D

Daniele Vigo

Assistant Director

View 9 more team members with Pro

Unlock Full Team Directory

Recent News

Cambrex Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised